Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Radaelli

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Neurology|February 15, 2022
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective studyAntonio Riccardo Buonomo, Giulio Viceconte, Massimiliano Calabrese, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|October 2, 2023
Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSDFrederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Annals of Clinical and Translational Neurology|July 9, 2021
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and FranceMaria Pia Sormani, Marco Salvetti, Pierre Labauge, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 14, 2025
Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSDFrederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2021
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosisMassimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, et al.
Multiple Sclerosis and Related Disorders|June 8, 2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple SclerosisMarta Ponzano, Irene Schiavetti, Francesca Bovis, et al.
Nature Medicine|January 9, 2023
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 studyAngela Genchi, Elena Brambilla, Francesca Sangalli, et al.
Multiple Sclerosis and Related Disorders|October 26, 2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Irene Schiavetti, Roberto Bergamaschi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 28, 2024
Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum DisordersFrederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2023
Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disordersFrederike Cosima Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Neurology|February 15, 2022
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective studyAntonio Riccardo Buonomo, Giulio Viceconte, Massimiliano Calabrese, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|October 2, 2023
Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSDFrederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Annals of Clinical and Translational Neurology|July 9, 2021
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and FranceMaria Pia Sormani, Marco Salvetti, Pierre Labauge, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 14, 2025
Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSDFrederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2021
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosisMassimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, et al.
Multiple Sclerosis and Related Disorders|June 8, 2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple SclerosisMarta Ponzano, Irene Schiavetti, Francesca Bovis, et al.
Nature Medicine|January 9, 2023
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 studyAngela Genchi, Elena Brambilla, Francesca Sangalli, et al.
Multiple Sclerosis and Related Disorders|October 26, 2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Irene Schiavetti, Roberto Bergamaschi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 28, 2024
Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum DisordersFrederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2023
Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disordersFrederike Cosima Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Pageof 9